Peter Smith

Director/Board Member at RYVU THERAPEUTICS S.A.

Health Technology

Consumer Services

Finance

Profile

Peter Smith is the founder of Remix Therapeutics, Inc., Amplify Medicines, Inc. Dr. Smith is currently an Advisor at Atlas Venture Advisors, Inc. since 2018 and a Member of the Supervisory Board at Ryvu Therapeutics SA since 2023.
Dr. Smith was Chief Scientific Officer at H3 Biomedicine, Inc. from 2011 to 2018.
Dr. Smith earned a doctorate from Newcastle University in 2000 and an undergraduate degree from the University of Sheffield Medical School in 1996.

Peter Smith active positions

Companies	Position	Start
RYVU THERAPEUTICS S.A.	Director/Board Member	14/06/2023
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases	Founder	-
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.	Consultant / Advisor	01/01/2018
Amplify Medicines, Inc. Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Develops pharmaceutical drugs	Founder	-

All active positions of Peter Smith

Former positions of Peter Smith

Companies	Position	End
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs	Corporate Officer/Principal	31/12/2018

See the detail of Peter Smith's experience

Training of Peter Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Smith's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements.	Finance
Newcastle University Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs	Commercial Services
Ryvu Therapeutics SA Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology	Health Technology
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases	Health Technology
Amplify Medicines, Inc. Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Develops pharmaceutical drugs	Health Technology
University of Sheffield Medical School University of Sheffield Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services